Blue Origin pad destroyed in explosion
Blue Origin's only New Glenn launch complex was destroyed during a hot fire test, setting back NASA's lunar program by at least a year.
Snapshot · This Week in Tech (Audio)
TWiT 1086: The Great Beagle Migration - Pope Leo XIV's 1st Encyclical & Ferrari's 1st EV
Explore episode
May 31, 2026
Where this was said
Blue Origin's Catastrophic New Glenn Explosion
At 7:45 · chapter starts 7:35
The most spectacular rocket explosion since the Soviet N1 in 1969 has just occurred in Florida, and Sam Abuelsamid walks the panel through exactly what happened: Blue Origin's New Glenn was undergoing a hot fire test — engines ignited while the vehicle remains clamped to the pad — when it exploded, destroying the facility that is the company's only New Glenn launch site. [1] — Sam Abuelsamid "Blue Origin's New Glenn rocket exploded during a hot fire test, destroying the company's only launchpad and setting back NASA's lunar progr…" 07:33 That means at least a year of rebuild time, directly threatening NASA's timeline for launching lunar rovers. Abuelsamid widens the lens to critique the environmental cost of the methane rocket era: liquid methane boils off continuously from cryogenic tanks even sitting on the pad, venting a greenhouse gas far more potent than CO2. Molly White sharpens the cultural critique, noting that Silicon Valley's 'move fast and break things' philosophy is now being applied to industries — space, government, critical infrastructure — where that ethos has genuinely catastrophic consequences.
Similar snapshots
540M years ago: first animal vision
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
50% of cortex involved in vision
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Human 6-year-olds learn tens of thousands of object categories
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
~3% of FDA drugs have unclear mechanisms
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
30–50% of phase 1 drugs fail to reach phase 2
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
BPC-157 published work: >80% from one group
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
~100 approved peptide drugs; ~150 in trials
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
BPC-157 founder withheld screening method
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
Brain barely distinguishes imagined vs real
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
